NeuroMetrix, Inc. (NURO)
NASDAQ: NURO · Real-Time Price · USD
4.340
-0.060 (-1.36%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NeuroMetrix Employees
NeuroMetrix had 13 employees as of December 31, 2024. The number of employees decreased by 13 or -50.00% compared to the previous year.
Employees
13
Change (1Y)
-13
Growth (1Y)
-50.00%
Revenue / Employee
$233,295
Profits / Employee
-$600,466
Market Cap
8.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
NURO News
- 3 months ago - NEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc. - NURO - Business Wire
- 4 months ago - NeuroMetrix to be Acquired by electroCore - GlobeNewsWire
- 9 months ago - NeuroMetrix Reiterates its Review of Strategic Alternatives - GlobeNewsWire
- 9 months ago - NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call - GlobeNewsWire
- 1 year ago - NeuroMetrix Reports Q1 2024 Business Highlights - GlobeNewsWire
- 1 year ago - NeuroMetrix Announces Steps Taken to Enhance Shareholder Value - GlobeNewsWire
- 1 year ago - NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy - GlobeNewsWire